DayDose ApS
CVR number: 39899043
Kalvebod Brygge 35, 1560 København V
info@abacusmedicine.com
tel: 33228322
www.daydose.com
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -5 476.00 | -1 828.00 | - 426.00 | - 187.00 | - 324.00 |
| Employee benefit expenses | -2 756.00 | - 304.00 | |||
| Total depreciation | -6 034.00 | -1 608.00 | -57.00 | ||
| EBIT | -14 266.00 | -3 740.00 | - 483.00 | - 187.00 | - 324.00 |
| Other financial income | 10.00 | 10.00 | 102.00 | 2.00 | 14.00 |
| Other financial expenses | - 709.00 | - 112.00 | -50.00 | -29.00 | -25.00 |
| Pre-tax profit | -14 965.00 | -3 842.00 | - 431.00 | - 214.00 | - 335.00 |
| Income taxes | 3 288.00 | 846.00 | 110.00 | 47.00 | 73.00 |
| Net earnings | -11 677.00 | -2 996.00 | - 321.00 | - 167.00 | - 262.00 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Development expenditure | 1 157.00 | ||||
| Intangible assets total | 1 157.00 | ||||
| Machinery and equipment | 232.00 | 57.00 | |||
| Tangible assets total | 232.00 | 57.00 | |||
| Investments total | |||||
| Deferred tax assets | 1 085.00 | 1 091.00 | 826.00 | 563.00 | 302.00 |
| Long term receivables total | 1 085.00 | 1 091.00 | 826.00 | 563.00 | 302.00 |
| Finished products/goods | 716.00 | 100.00 | |||
| Inventories total | 716.00 | 100.00 | |||
| Current trade debtors | 85.00 | ||||
| Current amounts owed by group member comp. | 2 169.00 | 840.00 | 370.00 | 680.00 | |
| Prepayments and accrued income | 7.00 | ||||
| Current other receivables | 318.00 | 16.00 | 34.00 | 30.00 | |
| Current deferred tax assets | 2 169.00 | 840.00 | 370.00 | 310.00 | 334.00 |
| Short term receivables total | 2 579.00 | 3 025.00 | 1 244.00 | 710.00 | 1 014.00 |
| Cash and bank deposits | 1 166.00 | 273.00 | 5.00 | 677.00 | 374.00 |
| Cash and cash equivalents | 1 166.00 | 273.00 | 5.00 | 677.00 | 374.00 |
| Balance sheet total (assets) | 6 935.00 | 4 546.00 | 2 075.00 | 1 950.00 | 1 690.00 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 250.00 | 250.00 | 250.00 | 250.00 | 250.00 |
| Retained earnings | 16 408.00 | 4 731.00 | 1 735.00 | 1 414.00 | 1 247.00 |
| Profit of the financial year | -11 677.00 | -2 996.00 | - 321.00 | - 167.00 | - 262.00 |
| Shareholders equity total | 4 981.00 | 1 985.00 | 1 664.00 | 1 497.00 | 1 235.00 |
| Non-current liabilities total | |||||
| Current trade creditors | 1 276.00 | 46.00 | 36.00 | 6.00 | 2.00 |
| Current owed to group member | 326.00 | 2 498.00 | 360.00 | 430.00 | 453.00 |
| Other non-interest bearing current liabilities | 352.00 | 17.00 | 15.00 | 17.00 | |
| Current liabilities total | 1 954.00 | 2 561.00 | 411.00 | 453.00 | 455.00 |
| Balance sheet total (liabilities) | 6 935.00 | 4 546.00 | 2 075.00 | 1 950.00 | 1 690.00 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.